Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.
OBJECTIVE: Though effective anti-human immunodeficiency virus (HIV) therapies are now available, they have variable penetration into the brain. We therefore aimed to assess changes over calendar time in the risk for HIV-associated dementia (HIV-D), and factors associated with HIV-D risk. METHODS: Us...
Hauptverfasser: | Bhaskaran, K, Mussini, C, Antinori, A, Walker, A, Dorrucci, M, Sabin, C, Phillips, A, Porter, K |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
2008
|
Ähnliche Einträge
Ähnliche Einträge
-
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
von: Marin, B, et al.
Veröffentlicht: (2009) -
Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
von: Wolbers, M, et al.
Veröffentlicht: (2010) -
Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
von: Sridharan Sudharshan, et al.
Veröffentlicht: (2020-01-01) -
Pulmonary toxoplasmosis in human immunodeficiency virus-infected patients in the era of antiretroviral therapy
von: Jorge N Velásquez, et al.
Veröffentlicht: (2016-01-01) -
Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
von: Bhaskaran, K, et al.
Veröffentlicht: (2004)